Success Metrics

Clinical Success Rate
84.7%

Based on 183 completed trials

Completion Rate
85%(183/216)
Active Trials
29(9%)
Results Posted
46%(85 trials)
Terminated
33(11%)

Phase Distribution

Ph phase_1
28
9%
Ph phase_3
74
24%
Ph phase_4
76
24%
Ph phase_2
62
20%
Ph early_phase_1
4
1%
Ph not_applicable
55
18%

Phase Distribution

32

Early Stage

62

Mid Stage

150

Late Stage

Phase Distribution299 total trials
Early Phase 1First-in-human
4(1.3%)
Phase 1Safety & dosage
28(9.4%)
Phase 2Efficacy & side effects
62(20.7%)
Phase 3Large-scale testing
74(24.7%)
Phase 4Post-market surveillance
76(25.4%)
N/ANon-phased studies
55(18.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.2%

183 of 234 finished

Non-Completion Rate

21.8%

51 ended early

Currently Active

29

trials recruiting

Total Trials

313

all time

Status Distribution
Active(33)
Completed(183)
Terminated(51)
Other(46)

Detailed Status

Completed183
unknown42
Terminated33
Recruiting20
Withdrawn18
Active, not recruiting9

Development Timeline

Analytics

Development Status

Total Trials
313
Active
29
Success Rate
84.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (1.3%)
Phase 128 (9.4%)
Phase 262 (20.7%)
Phase 374 (24.7%)
Phase 476 (25.4%)
N/A55 (18.4%)

Trials by Status

withdrawn186%
not_yet_recruiting41%
completed18358%
recruiting206%
suspended41%
unknown4213%
active_not_recruiting93%
terminated3311%

Recent Activity

Clinical Trials (313)

Showing 20 of 313 trialsScroll for more
NCT06082037Phase 3

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

Recruiting
NCT07433426Phase 2

The Impact of Shigellosis and Recommended Treatment in Children

Recruiting
NCT04235816Phase 3

Improving Care Through Azithromycin Research for Infants in Africa

Active Not Recruiting
NCT04185402Phase 4

Azithromycin Reduction to Reach Elimination of Trachoma

Completed
NCT04287049Phase 2

A Study of Standard Drugs for Mycobacterium Avium Complex

Completed
NCT05994742Phase 3

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Active Not Recruiting
NCT01233297Phase 2

Antibiotic Treatment of Recurrent Episodes of Asthma in Children

Active Not Recruiting
NCT06289647Phase 4

Azithromycin Reduction to Reach Elimination of Trachoma B

Withdrawn
NCT06488781Phase 2

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0

Recruiting
NCT04069312Phase 4

Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

Completed
NCT05949190Not Applicable

Improving Cognition and Gestational Duration With Targeted Nutrition

Active Not Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT05922761Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Recruiting
NCT07394725Phase 1

Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management

Completed
NCT04677569Phase 3

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Completed
NCT03672630Phase 2

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Completed
NCT04481555Phase 4

Eosinophil-guided Reduction of Inhaled Corticosteroids

Completed
NCT06396078Phase 4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Recruiting
NCT04294641Phase 2

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Completed
NCT06077916Not Applicable

Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
313